Rotavirus serotype G9 Is associated with more-severe disease in Latin America

Detalhes bibliográficos
Autor(a) principal: Linhares, Alexandre da Costa
Data de Publicação: 2006
Outros Autores: Verstraeten, Thomas, Wolleswinkel-van den Bosch, Judith, Clemens, Ralf, Breuer, Thomas
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Digital do Instituto Evandro Chagas (Patuá)
Texto Completo: https://patua.iec.gov.br/handle/iec/1074
Resumo: The association between rotavirus serotypes and severity is not well established. Analysis of a clinical trial conducted in Latin America points at more-severe disease associated with serotype G9. Thus, demonstration of efficacy against G9 will be an important asset of any rotavirus vaccine to be introduced into a Latin American country or any country where G9 has been shown to be prevalent.
id IEC-2_b4f3f2664b77fb656940e66d975d049e
oai_identifier_str oai:patua.iec.gov.br:iec/1074
network_acronym_str IEC-2
network_name_str Repositório Digital do Instituto Evandro Chagas (Patuá)
repository_id_str
spelling Linhares, Alexandre da CostaVerstraeten, ThomasWolleswinkel-van den Bosch, JudithClemens, RalfBreuer, Thomas2016-01-26T11:43:44Z2016-01-26T11:43:44Z2006LINHARES, Alexandre da Costa et al. Rotavirus serotype G9 Is associated with more-severe disease in Latin America. Clinical Infectious Diseases, v. 43, n. 3, p. 312-314, Aug. 20061058-4838https://patua.iec.gov.br/handle/iec/1074The association between rotavirus serotypes and severity is not well established. Analysis of a clinical trial conducted in Latin America points at more-severe disease associated with serotype G9. Thus, demonstration of efficacy against G9 will be an important asset of any rotavirus vaccine to be introduced into a Latin American country or any country where G9 has been shown to be prevalent.Ministério da Saúde. Secretaria de Vigilância em Saúde. Instituto Evandro Chagas. Belém, PA, Brasil.GlaxoSmithKline Biologicals. Rixensart, Belgium.Pallas Health Research and Consultancy. Rotterdam.GlaxoSmithKline Biologicals. Rio de Janeiro, RJ, Brasil.GlaxoSmithKline Biologicals. Rixensart, Belgium.application/pdfengOxford University PressRotavirus serotype G9 Is associated with more-severe disease in Latin Americainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleRotavirus / classificaçãoInfecções por Rotavirus / epidemiologiaGastroenteriteVacinas contra Rotavirus / uso terapêuticoAmérica Latinainfo:eu-repo/semantics/openAccessreponame:Repositório Digital do Instituto Evandro Chagas (Patuá)instname:Instituto Evandro Chagas (IEC)instacron:IECORIGINALRotavirus serotype G9 Is associated with more-severe disease in Latin America .pdfapplication/pdf73054https://patua.iec.gov.br/bitstreams/d6e03ca9-931d-4d82-9460-e23ffaa220fb/download7495bc04b651c47fd8f70724a6a20616MD51TEXTfile_1.pdf.txtfile_1.pdf.txtExtracted texttext/plain12978https://patua.iec.gov.br/bitstreams/1adb508f-98cd-48d0-aff9-515b86212969/downloadd36b6e3ce75af46387bf484004f9539dMD52Rotavirus serotype G9 Is associated with more-severe disease in Latin America .pdf.txtRotavirus serotype G9 Is associated with more-severe disease in Latin America .pdf.txtExtracted texttext/plain13164https://patua.iec.gov.br/bitstreams/af177985-8201-4f59-b0ce-2790598d0382/downloadeff54f9958bb41b356e0946173a66811MD56THUMBNAILRotavirus serotype G9 Is associated with more-severe disease in Latin America .pdf.jpgRotavirus serotype G9 Is associated with more-severe disease in Latin America .pdf.jpgGenerated Thumbnailimage/jpeg6069https://patua.iec.gov.br/bitstreams/aaafafd0-ccc9-4d81-ba5b-0bef529e8c3a/download64b2d16271790e3b1ab4bc9bc61b0ed2MD57LICENSElicense.txtlicense.txttext/plain; charset=utf-82182https://patua.iec.gov.br/bitstreams/d70298a4-abf8-4277-b3b0-41f89707970a/download11832eea31b16df8613079d742d61793MD55iec/10742022-10-20 21:07:59.377oai:patua.iec.gov.br:iec/1074https://patua.iec.gov.brRepositório InstitucionalPUBhttps://patua.iec.gov.br/oai/requestclariceneta@iec.gov.br || Biblioteca@iec.gov.bropendoar:2022-10-20T21:07:59Repositório Digital do Instituto Evandro Chagas (Patuá) - Instituto Evandro Chagas (IEC)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
dc.title.pt_BR.fl_str_mv Rotavirus serotype G9 Is associated with more-severe disease in Latin America
title Rotavirus serotype G9 Is associated with more-severe disease in Latin America
spellingShingle Rotavirus serotype G9 Is associated with more-severe disease in Latin America
Linhares, Alexandre da Costa
Rotavirus / classificação
Infecções por Rotavirus / epidemiologia
Gastroenterite
Vacinas contra Rotavirus / uso terapêutico
América Latina
title_short Rotavirus serotype G9 Is associated with more-severe disease in Latin America
title_full Rotavirus serotype G9 Is associated with more-severe disease in Latin America
title_fullStr Rotavirus serotype G9 Is associated with more-severe disease in Latin America
title_full_unstemmed Rotavirus serotype G9 Is associated with more-severe disease in Latin America
title_sort Rotavirus serotype G9 Is associated with more-severe disease in Latin America
author Linhares, Alexandre da Costa
author_facet Linhares, Alexandre da Costa
Verstraeten, Thomas
Wolleswinkel-van den Bosch, Judith
Clemens, Ralf
Breuer, Thomas
author_role author
author2 Verstraeten, Thomas
Wolleswinkel-van den Bosch, Judith
Clemens, Ralf
Breuer, Thomas
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Linhares, Alexandre da Costa
Verstraeten, Thomas
Wolleswinkel-van den Bosch, Judith
Clemens, Ralf
Breuer, Thomas
dc.subject.decsPrimary.pt_BR.fl_str_mv Rotavirus / classificação
Infecções por Rotavirus / epidemiologia
Gastroenterite
Vacinas contra Rotavirus / uso terapêutico
América Latina
topic Rotavirus / classificação
Infecções por Rotavirus / epidemiologia
Gastroenterite
Vacinas contra Rotavirus / uso terapêutico
América Latina
description The association between rotavirus serotypes and severity is not well established. Analysis of a clinical trial conducted in Latin America points at more-severe disease associated with serotype G9. Thus, demonstration of efficacy against G9 will be an important asset of any rotavirus vaccine to be introduced into a Latin American country or any country where G9 has been shown to be prevalent.
publishDate 2006
dc.date.issued.fl_str_mv 2006
dc.date.accessioned.fl_str_mv 2016-01-26T11:43:44Z
dc.date.available.fl_str_mv 2016-01-26T11:43:44Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv LINHARES, Alexandre da Costa et al. Rotavirus serotype G9 Is associated with more-severe disease in Latin America. Clinical Infectious Diseases, v. 43, n. 3, p. 312-314, Aug. 2006
dc.identifier.uri.fl_str_mv https://patua.iec.gov.br/handle/iec/1074
dc.identifier.issn.-.fl_str_mv 1058-4838
identifier_str_mv LINHARES, Alexandre da Costa et al. Rotavirus serotype G9 Is associated with more-severe disease in Latin America. Clinical Infectious Diseases, v. 43, n. 3, p. 312-314, Aug. 2006
1058-4838
url https://patua.iec.gov.br/handle/iec/1074
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Oxford University Press
publisher.none.fl_str_mv Oxford University Press
dc.source.none.fl_str_mv reponame:Repositório Digital do Instituto Evandro Chagas (Patuá)
instname:Instituto Evandro Chagas (IEC)
instacron:IEC
instname_str Instituto Evandro Chagas (IEC)
instacron_str IEC
institution IEC
reponame_str Repositório Digital do Instituto Evandro Chagas (Patuá)
collection Repositório Digital do Instituto Evandro Chagas (Patuá)
bitstream.url.fl_str_mv https://patua.iec.gov.br/bitstreams/d6e03ca9-931d-4d82-9460-e23ffaa220fb/download
https://patua.iec.gov.br/bitstreams/1adb508f-98cd-48d0-aff9-515b86212969/download
https://patua.iec.gov.br/bitstreams/af177985-8201-4f59-b0ce-2790598d0382/download
https://patua.iec.gov.br/bitstreams/aaafafd0-ccc9-4d81-ba5b-0bef529e8c3a/download
https://patua.iec.gov.br/bitstreams/d70298a4-abf8-4277-b3b0-41f89707970a/download
bitstream.checksum.fl_str_mv 7495bc04b651c47fd8f70724a6a20616
d36b6e3ce75af46387bf484004f9539d
eff54f9958bb41b356e0946173a66811
64b2d16271790e3b1ab4bc9bc61b0ed2
11832eea31b16df8613079d742d61793
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Digital do Instituto Evandro Chagas (Patuá) - Instituto Evandro Chagas (IEC)
repository.mail.fl_str_mv clariceneta@iec.gov.br || Biblioteca@iec.gov.br
_version_ 1787533055223660544

Registros relacionados